Hunt Globally: Deep Research AI Agents for Drug Asset Scouting in Investing, Business Development, and Search & Evaluation

Hunt Globally: Deep Research AI Agents for Drug Asset Scouting in Investing, Business Development, and Search & Evaluation | Signal Canvas | ScienceToStartup

Page Freshness

Signal Canvas proof surface

Canonical route: /signal-canvas/hunt-globally-deep-research-ai-agents-for-drug-asset-scouting-in-investing-business-development-and-search-evaluation

degraded

Proof freshness: stale
Proof status: failed
Display score: 8/10
Last proof check: 2026-03-19
Score updated: 2026-04-02
Score fresh until: 2026-05-02
References: 0
Source count: 0
Coverage: 33%

This page has proof data, but the latest verification did not complete cleanly.

Agent Handoff

Canonical ID hunt-globally-deep-research-ai-agents-for-drug-asset-scouting-in-investing-business-development-and-search-evaluation | Route /signal-canvas/hunt-globally-deep-research-ai-agents-for-drug-asset-scouting-in-investing-business-development-and-search-evaluation

REST example

curl https://sciencetostartup.com/api/v1/agent-handoff/signal-canvas/hunt-globally-deep-research-ai-agents-for-drug-asset-scouting-in-investing-business-development-and-search-evaluation

MCP example

{
  "tool": "search_signal_canvas",
  "arguments": {
    "mode": "paper",
    "paper_ref": "hunt-globally-deep-research-ai-agents-for-drug-asset-scouting-in-investing-business-development-and-search-evaluation",
    "query_text": "Summarize Hunt Globally: Deep Research AI Agents for Drug Asset Scouting in Investing, Business Development, and Search & Evaluation"
  }
}

source_context

{
  "surface": "signal_canvas",
  "mode": "paper",
  "query": "Hunt Globally: Deep Research AI Agents for Drug Asset Scouting in Investing, Business Development, and Search & Evaluation",
  "normalized_query": "2602.15019",
  "route": "/signal-canvas/hunt-globally-deep-research-ai-agents-for-drug-asset-scouting-in-investing-business-development-and-search-evaluation",
  "paper_ref": "hunt-globally-deep-research-ai-agents-for-drug-asset-scouting-in-investing-business-development-and-search-evaluation",
  "topic_slug": null,
  "benchmark_ref": null,
  "dataset_ref": null
}

Evidence Receipt

Route status: degraded

Claims: 8

References: Pending verification

Proof: Verification pending

Freshness state: stale

Source paper: Hunt Globally: Deep Research AI Agents for Drug Asset Scouting in Investing, Business Development, and Search & Evaluation

PDF: https://arxiv.org/pdf/2602.15019v1

Source count: Pending verification

Coverage: 33%

Last proof check: 2026-03-19T21:31:49.672Z

Signal Canvas receipt window

Watch and verify: Hunt Globally: Deep Research AI Agents for Drug Asset Scouting in Investing, Business Development, and Search & Evaluation

/buildability/hunt-globally-deep-research-ai-agents-for-drug-asset-scouting-in-investing-business-development-and-search-evaluation

Watchwatch

Subject: Hunt Globally: Deep Research AI Agents for Drug Asset Scouting in Investing, Business Development, and Search & Evaluation

Verdict

Preparing verified analysis

GitHub Code Pulse

No public code linked for this paper yet.

Claim map

Strong 8Mixed 0Weak 0

Evidencepartial
Bioptic Agent achieves 79.7% F1 versus 56.2% (Claude Opus 4.6), 50.6% (Gemini 3 Pro + Deep Research), 46.6% (GPT-5.2 Pro), 44.2% (Perplexity Deep Research), and 26.9% (Exa Websets).
Implicationpartial
Directly stated in abstract with specific numeric results comparing multiple systems
Verificationpartial
partial
Evidencepartial
Recent data suggests >85% of patent filings originate outside the U.S., with China accounting for nearly half of the global total
Implicationpartial
Explicitly stated in abstract with specific percentage data
Verificationpartial
partial
Evidencepartial
Industry estimates put China at ~30% of global drug development, spanning 1,200+ novel candidates.
Implicationpartial
Directly stated in abstract with specific numeric data
Verificationpartial
partial
Evidencepartial
Performance improves steeply with additional compute, supporting the view that more compute yields better results.
Implicationpartial
Directly stated in abstract as a conclusion from the research
Verificationpartial
partial
Evidencepartial
We propose a benchmarking methodology for drug asset scouting and a tuned, tree-based self-learning Bioptic Agent aimed at complete, non-hallucinated scouting.
Implicationpartial
Directly stated in abstract describing the method
Verificationpartial
partial
Evidencepartial
We construct a challenging completeness benchmark using a multilingual multi-agent pipeline: complex user queries paired with ground-truth assets that are largely outside U.S.-centric radar.
Implicationpartial
Directly stated in abstract describing the benchmarking methodology
Verificationpartial
partial
Evidencepartial
The system's performance may degrade with languages not included in its training scope or with assets disclosed in less accessible sources.
Implicationpartial
Directly stated in analysis section as a caveat
Verificationpartial
partial
Evidencepartial
Yet today's Deep Research AI agents still lag human experts in achieving high-recall discovery across heterogeneous, multilingual sources without hallucinations.
Implicationpartial
Directly stated in abstract as a problem statement
Verificationpartial
partial

Author intelligence and commercialization panels stay hidden until the proof receipt is verified, cites at least 3 references, includes at least 2 sources, and clears 50% coverage. The paper narrative and citation surfaces remain public while verification is pending.

Hunt Globally: Deep Research AI Agents for Drug Asset Scouting in Investing, Business Development, and Search & Evaluation

Use Signal Canvas as the narrative proof surface

Use this Signal Canvas via API or MCP

Signal Canvas proof surface